CCS
Basic information
Region (hg38): 11:66593153-66606019
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CCS gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 19 | 19 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 20 | 1 | 1 |
Variants in CCS
This is a list of pathogenic ClinVar variants found in the CCS region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-66593691-G-A | not specified | Uncertain significance (Dec 08, 2023) | ||
11-66593709-T-G | not specified | Uncertain significance (May 24, 2024) | ||
11-66599209-C-T | not specified | Uncertain significance (Sep 26, 2023) | ||
11-66599214-C-T | not specified | Uncertain significance (Jan 10, 2022) | ||
11-66599487-G-T | CCS-related disorder | Likely benign (Mar 02, 2020) | ||
11-66599515-G-C | not specified | Uncertain significance (Dec 07, 2022) | ||
11-66599557-G-A | not specified | Uncertain significance (Jun 24, 2022) | ||
11-66599618-T-C | not specified | Uncertain significance (Feb 15, 2023) | ||
11-66600509-C-T | not specified | Uncertain significance (Apr 22, 2022) | ||
11-66600547-C-T | Neurodegeneration | Uncertain significance (Aug 01, 2012) | ||
11-66600548-G-T | not specified | Uncertain significance (Sep 20, 2023) | ||
11-66605384-G-A | not specified | Uncertain significance (Aug 09, 2021) | ||
11-66605406-A-G | not specified | Uncertain significance (Dec 22, 2023) | ||
11-66605417-G-C | Uncertain significance (Dec 03, 2020) | |||
11-66605547-G-A | not specified | Uncertain significance (May 23, 2023) | ||
11-66605563-A-C | not specified | Uncertain significance (Aug 22, 2023) | ||
11-66605713-G-C | not specified | Uncertain significance (Mar 28, 2023) | ||
11-66605730-G-A | not specified | Uncertain significance (Dec 19, 2023) | ||
11-66605746-A-G | not specified | Uncertain significance (Aug 21, 2023) | ||
11-66605805-A-G | not specified | Uncertain significance (Apr 18, 2024) | ||
11-66605808-G-A | not specified | Uncertain significance (Oct 29, 2021) | ||
11-66605808-G-T | not specified | Uncertain significance (Sep 14, 2023) | ||
11-66605818-G-C | not specified | Uncertain significance (Jul 14, 2021) | ||
11-66605834-G-A | CCS-related disorder | Benign (Nov 12, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CCS | protein_coding | protein_coding | ENST00000533244 | 8 | 13199 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
8.63e-8 | 0.305 | 125668 | 0 | 80 | 125748 | 0.000318 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.400 | 156 | 171 | 0.914 | 0.0000107 | 1756 |
Missense in Polyphen | 54 | 58.298 | 0.92628 | 563 | ||
Synonymous | 1.16 | 56 | 68.2 | 0.821 | 0.00000442 | 557 |
Loss of Function | 0.528 | 12 | 14.1 | 0.848 | 7.67e-7 | 149 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000528 | 0.000526 |
Ashkenazi Jewish | 0.000235 | 0.000198 |
East Asian | 0.000329 | 0.000326 |
Finnish | 0.0000953 | 0.0000924 |
European (Non-Finnish) | 0.000417 | 0.000413 |
Middle Eastern | 0.000329 | 0.000326 |
South Asian | 0.000218 | 0.000196 |
Other | 0.000666 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Delivers copper to copper zinc superoxide dismutase (SOD1).;
- Pathway
- Amyotrophic lateral sclerosis (ALS) - Homo sapiens (human);Amyotrophic lateral sclerosis (ALS);Copper homeostasis;Detoxification of Reactive Oxygen Species;Cellular responses to stress;Cellular responses to external stimuli
(Consensus)
Recessive Scores
- pRec
- 0.326
Intolerance Scores
- loftool
- 0.339
- rvis_EVS
- -0.23
- rvis_percentile_EVS
- 37.32
Haploinsufficiency Scores
- pHI
- 0.0676
- hipred
- N
- hipred_score
- 0.368
- ghis
- 0.547
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.847
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ccs
- Phenotype
- endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; cellular phenotype; reproductive system phenotype;
Gene ontology
- Biological process
- superoxide metabolic process;protein maturation by copper ion transfer;removal of superoxide radicals;metal ion transport;cellular response to oxidative stress;positive regulation of oxidoreductase activity;oxidation-reduction process
- Cellular component
- extracellular space;nucleus;cytoplasm;cytosol
- Molecular function
- superoxide dismutase activity;copper ion binding;protein binding;zinc ion binding;protein disulfide oxidoreductase activity;superoxide dismutase copper chaperone activity;cadherin binding